Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
September 30, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees
Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
September 30, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees
Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
September 30, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees
Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
September 16, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees
Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
September 16, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees
Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
September 9, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees
Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
August 5, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees
Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
July 29, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees
Abstract: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
July 15, 2003
Assignee:
Syn X Pharma, Inc.
Inventors:
George Jackowski, Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees